Listen

Lou Gehrig's Disease

OSU Medical Center

Researchers in Columbus and Ann Arbor, Michigan say a cell discovery shows potential for unprecedented recovery from many brain and spine diseases and injuries.

A combination of two experimental drugs appears to slow the decline of patients with amyotrophic lateral sclerosis, an illness often known as ALS or Lou Gehrig's disease.

A six-month study of 137 patients with a fast-progressing form of the disease found that those who got daily doses of a two-drug combination called AMX0035 scored several points higher on a standard measure of function, a team reports in the Sept. 3 issue of The New England Journal of Medicine.

Facebook

The "Drag Queen Story Hour" fundraiser was held at Studio 35 in Clintonville last night, after Clinton Elementary School canceled the event due to what officials said were "outside agitators." 

cleveland.com

Former Cleveland Browns general manager Dwight Clark has passed away from complications of ALS.